Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.66 CAD | -.--% |
|
+1.54% | -10.81% |
Chart calendar Valeo Pharma Inc.
Upcoming events on Valeo Pharma Inc.
Past events on Valeo Pharma Inc.
2024-06-14 08:30 am | Q2 2024 Earnings Call |
2024-06-13 05:00 pm | Q2 2024 Earnings Release |
2024-04-25 10:30 am | Annual General Meeting |
2024-04-17 04:00 pm | Bloom Burton & Co. Healthcare Investor Conference |
2024-03-15 08:30 am | Q1 2024 Earnings Call |
2024-03-14 04:09 pm | Q1 2024 Earnings Release |
2024-01-30 08:30 am | Q4 2023 Earnings Call |
2024-01-29 05:48 pm | Q4 2023 Earnings Release |
2023-09-14 08:30 am | Q3 2023 Earnings Call |
2023-09-13 04:50 pm | Q3 2023 Earnings Release |
2023-06-14 08:30 am | Q2 2023 Earnings Call |
2023-06-13 04:43 pm | Q2 2023 Earnings Release |
2023-04-27 10:30 am | Annual General Meeting |
2023-04-25 11:00 am | Bloom Burton & Co Healthcare Investor Conference |
2023-03-16 08:30 am | Q1 2023 Earnings Call |
2023-03-15 05:00 pm | Q1 2023 Earnings Release |
2023-03-09 11:30 am | OTC Life Science Investor Forum |
2023-01-31 08:30 am | FY 2022 Earnings Call |
2023-01-30 04:50 pm | FY 2022 Earnings Release |
2022-09-14 08:30 am | Q3 2022 Earnings Call |
Annual results
Fiscal Period | October | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million CAD | Released Forecast Spread | 6,58 | 7,47 8,00 -6.63% | 13,6 14,6 -7.14% | 27,7 27,4 1.25% | 53,9 56,9 -5.3% | 57,7 |
EBITDA Million CAD | Released Forecast Spread | 0,00 | -2,60 -0,80 -225% | -12,2 -9,10 -33.81% | -14,5 -14,8 1.9% | -10,9 -7,78 -40.07% | -5,15 |
EBIT Million CAD | Released Forecast Spread | 0,00 | -4,34 -1,00 -334.3% | -12,9 -11,0 -17.64% | -19,6 -14,8 -32.36% | -17,2 -12,3 -39.72% | 0,00 |
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -26,9 -19,7 -36.89% | -27,8 -24,5 -13.63% | 0,00 |
Net income Million CAD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -25,7 -19,7 -30.69% | -27,8 -24,5 -13.63% | 0,00 |
EPS CAD | Released Forecast Spread | -0,07 | 0,00 0,00 - | 0,00 0,00 - | -0,32 -0,24 -33.33% | -0,32 -0,29 -12.28% | -0,24 |
Announcement Date | 27/02/20 | 24/02/21 | 28/02/22 | 30/01/23 | 29/01/24 | - |
Quarterly results
Fiscal Period | October | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million CAD | Released Forecast Spread | 4,77 6,49 -26.52% | 6,07 6,02 0.86% | 12,7 12,7 -0.24% | 13,2 13,1 0.39% | 13,6 13,9 -2.55% | 14,1 16,4 -14.04% | 13,1 16,1 -18.71% | 13,5 14,4 -5.98% | 14,1 15,5 -8.85% | 13,5 | 16,0 |
EBITDA Million CAD | Released Forecast Spread | -3,78 -3,39 -11.46% | -2,90 -3,16 8.22% | -2,90 -1,67 -73.24% | -2,21 -2,85 22.39% | -1,69 -2,10 19.47% | -2,50 -1,43 -75.23% | -4,50 -1,34 -236.2% | -2,08 -2,46 15.41% | -3,21 -2,20 -45.82% | -0,90 | 1,30 |
EBIT Million CAD | Released Forecast Spread | -3,94 -3,86 -2.07% | -3,53 -3,93 10.28% | -7,24 -2,63 -175.39% | -3,86 -3,44 -12.2% | -2,80 -2,91 3.61% | -3,43 -2,20 -55.7% | -7,13 -2,24 -219.05% | -4,86 | -3,89 | ||
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -5,10 -4,57 -11.68% | -4,74 -4,73 -0.19% | -11,2 -3,97 -182.97% | -6,25 -6,09 -2.6% | -6,48 -5,70 -13.58% | -5,84 -4,67 -25.06% | -5,46 -5,91 7.7% | -6,87 -6,12 -12.23% | -7,81 -5,05 -54.73% | ||
Net income Million CAD | Released Forecast Spread | -5,10 -4,57 -11.68% | -4,74 -4,73 -0.19% | -9,30 -3,97 -134.46% | -6,25 -6,09 -2.6% | -6,48 -5,70 -13.58% | -5,80 -4,67 -24.25% | -5,46 -5,91 7.7% | -6,87 | -7,81 | ||
EPS CAD | Released Forecast Spread | -0,06 -0,06 0% | -0,06 -0,06 -9.09% | -0,13 -0,05 -160% | -0,08 -0,08 -6.67% | -0,08 -0,07 -14.29% | -0,07 -0,06 -23.52% | -0,10 -0,07 -53.85% | -0,08 -0,08 -6.67% | -0,08 -0,05 -60% | -0,05 | -0,03 |
Announcement Date | 14/06/22 | 13/09/22 | 30/01/23 | 15/03/23 | 13/06/23 | 13/09/23 | 29/01/24 | 14/03/24 | 13/06/24 | - | - |
2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | INNOVIVA, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Valeo Pharma Inc.
2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2024-07-09 | LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release |
2024-07-09 07:35 am | SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release |
2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
2024-07-02 05:05 am | ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VPH Stock
- VPH Stock
- Calendar Valeo Pharma Inc.